Foresite Capital Management V, LLC

SEC Form 4 insider trading activity

Foresite Capital Management V, LLC has filed 1 SEC Form 4 filing (8 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.

On the most recent filing, Foresite Capital Management V, LLC is listed as 10% Owner at Latigo Biotherapeutics, Inc. Inside the rolling window, Foresite Capital Management V, LLC reported 1 open-market purchase totaling $2.5M in LTGO and no open-market sales.

Companies traded

Other insiders at LTGO

Insider Buying

$2.5M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LTGO
Foresite Capital Management V, LLC
Purchase$2.5MAug 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Foresite Capital Management V, LLC made?

Foresite Capital Management V, LLC has filed 1 SEC Form 4 filing (8 transaction rows) across 1 company since 2026.

Which companies does Foresite Capital Management V, LLC trade?

Foresite Capital Management V, LLC has filed SEC Form 4 disclosures for 1 company, including LTGO.

When was Foresite Capital Management V, LLC's most recent SEC Form 4 filing?

Foresite Capital Management V, LLC's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.

What is Foresite Capital Management V, LLC's total buy and sell value in the current window?

Inside the rolling retention window, Foresite Capital Management V, LLC bought $2.5M and sold $0 based on SEC Form 4 filings.

What was Foresite Capital Management V, LLC's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 140,000 LTGO shares on 2026-08-10, worth $2.5M, per SEC Form 4 filings.